Clinical Trials Directory

Trials / Unknown

UnknownNCT00959205

The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT

Phase Ⅳ Study of CARTO 3D Mapping System vs Conventional Method in AF & VT

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
160 (estimated)
Sponsor
Korea University · Academic / Other
Sex
All
Age
20 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of electroanatomic imaging compared to conventional method in patients with VT.

Detailed description

To evaluate the efficacy and safety of electroanatomic imaging (CARTO) compared to conventional fluoroscopically guided activation mapping (Conventional) method in patients with Atrial Fibrillation and Substrate-dependent Ventricular Tachycardia To evaluate cost-effectiveness of CARTO 3D image system compared to conventional method in the same study subjects

Conditions

Interventions

TypeNameDescription
DEVICECARTO 3DCARTO (3D Electroanatomic imaging)
DEVICEAngiographyConventional fluoroscopically guided activation mapping

Timeline

Start date
2009-07-01
Primary completion
2010-06-01
Completion
2011-02-01
First posted
2009-08-14
Last updated
2010-05-20

Locations

5 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00959205. Inclusion in this directory is not an endorsement.

The Efficacy and Safety of CARTO 3D Mapping System Versus Conventional Method in AF and VT (NCT00959205) · Clinical Trials Directory